|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/635 |
| (11) | Number of the document | 1355631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01965984.6 |
| Date of filing the European patent application | 2001-08-17 | |
| (97) | Date of publication of the European application | 2003-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/025803 |
| Date | 2001-08-17 |
| (87) | Number | WO 2002/015885 |
| Date | 2002-02-28 |
| (30) | Number | Date | Country code |
| 226347 P | 2000-08-18 | US |
| (72) |
LE, Trang, T., US
KARARLI, Tugrul, T., US
KONTNY, Mark, J., US
SASTRY, Srikonda, V., US
NYSHADHAM, Janaki, R., US
PAGLIERO, Arthur, J., Jr., US
|
| (73) |
Pharmacia Corporation,
100 Route 206 North, Peapack, NJ 07977,
US
Astellas Pharma Technologies, Inc., 1050 Arastradero Road, Palo Alto, CA 94304, US |
| (54) | ORAL FAST-MELT FORMULATION OF A CYCLOOXYGENASE-2 INHIBITOR |
| ORAL FAST-MELT FORMULATION OF A CYCLOOXYGENASE-2 INHIBITOR |